FDA Approves Alzheimer's Drug Despite Fierce Debate Over Whether It Works

The drug, aducanumab, which will go by the brand name Aduhelm, is a monthly intravenous infusion intended to slow cognitive decline in people with mild memory and thinking problems. It is the first approved treatment to attack the disease process of ...

source https://www.google.com/url?rct=j&sa=t&url=https://www.nytimes.com/2021/06/07/health/aduhelm-fda-alzheimers-drug.html&ct=ga&cd=CAIyGjJhZjcxZTMyNjk0YzRkZjQ6Y29tOmVuOlVT&usg=AFQjCNGX2Rp1h5deqMfpdC_DUadbGJGAfw